Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2012
02/28/2012US8124077 Anti-IL-TIF antibodies and methods of making
02/28/2012US8124074 Fusion proteins
02/28/2012US8124069 Immunogenic peptides
02/28/2012US8124066 Methods of using interleukin-2 mutants with reduced toxicity
02/28/2012US8124065 Cytokine Protein Family
02/28/2012US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits
02/28/2012CA2633281C Novel mutations relating to x-linked charcot-marie-tooth disease
02/28/2012CA2592071C Transcription factor gene osnacx from rice and use thereof for improving plant tolerance to drought and salt
02/28/2012CA2511986C Method for purification of alpha-1-antitrypsin
02/28/2012CA2485506C A method for in vitro molecular evolution of protein function
02/28/2012CA2392202C Constructs for delivery of therapeutic agents to neuronal cells
02/28/2012CA2339901C Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences
02/23/2012WO2012024632A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
02/23/2012WO2012024621A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
02/23/2012WO2012024452A2 Modified relaxin polypeptides and their uses
02/23/2012WO2012024372A2 Novel bacillus thuringiensis gene with coleopteran activity
02/23/2012WO2012024236A1 LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS
02/23/2012WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
02/23/2012WO2012024200A2 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012WO2012024176A2 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012WO2012023579A1 Process for production of streptavidin
02/23/2012WO2012023486A1 Antifreeze protein
02/23/2012WO2012023290A1 Rasef as tumor marker and therapeutic target for cancer
02/23/2012WO2012023288A1 Fam161a as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023284A1 Lhx4 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023259A1 C6orf167 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023020A1 Diagnostic assays for the detection and identification of aspergilli
02/23/2012WO2012022928A2 Biological materials and uses thereof
02/23/2012WO2012022894A1 Novel peptides which have analgesic effects and which inhibit asic channels
02/23/2012WO2012022811A1 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain
02/23/2012WO2012022742A1 Binding proteins for hepcidin
02/23/2012WO2012022486A1 In vivo imaging of calcified lesions
02/23/2012WO2012022040A1 Hiv-1 virus membrane fusion inhibitor and use thereof
02/23/2012WO2012006732A9 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
02/23/2012WO2012001139A9 Variants of glucoamylase
02/23/2012WO2011160827A3 Novel jnk inhibitor molecules
02/23/2012WO2011157819A3 Peptides as active agents to stabilize biological barriers
02/23/2012WO2011157713A3 Cell-penetrating peptides and uses therof
02/23/2012WO2011154895A3 Polynucleotide sequence, processes, composition and methods thereof
02/23/2012WO2011126576A3 Genetic signatures in the envelope glycoprotein of hiv-1
02/23/2012WO2011123683A3 Protease activated cytokines
02/23/2012WO2011097181A3 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
02/23/2012WO2003099989A3 Compositions and methods relating to breast specific genes and proteins
02/23/2012US20120047608 Floral Transition Genes in Maize and Uses Thereof
02/23/2012US20120047607 Novel Bacillus thuringiensis Gene with Coleopteran Activity
02/23/2012US20120047606 Novel Bacillus thuringiensis Gene with Lepidopteran Activity
02/23/2012US20120047605 Novel Bacillus thuringiensis Gene with Lepidopteran Activity
02/23/2012US20120047591 Soybean variety a1024720
02/23/2012US20120046737 Medical devices having activated surfaces
02/23/2012US20120046638 Method of inducing a CTL response
02/23/2012US20120046453 Protein charge regulator and protein-encapsulating polymer micelle complex
02/23/2012US20120046449 production of protein solutions from soy
02/23/2012US20120046448 Chlamydomonas intraflagellar transport 88 (ift-88)
02/23/2012US20120046447 Method for producing conjugate of thyroxine and albumin
02/23/2012US20120046446 p16 MEDIATED REGULATION OF NMDA RECEPTORS
02/23/2012US20120046444 Peptide networks
02/23/2012US20120046443 Novel biomimetic peptoid polymers
02/23/2012US20120046349 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
02/23/2012US20120046240 Method of Producing Hydroxyalkyl Starch Derivatives
02/23/2012US20120046231 Composition and process for synthesizing polymerized human serum albumin for applications in transfusion medicine
02/23/2012US20120046229 Modified relaxin polypeptides and their uses
02/23/2012US20120046227 Designer osteogenic proteins
02/23/2012US20120046225 Stable glucagon formulations for the treatment of hypoglycemia
02/23/2012US20120046223 Exogenously triggered controlled release materials and uses thereof
02/23/2012US20120046222 N-terminus conformationally constrained glp-1 receptor agonist compounds
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120046218 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120046184 method for the selective concentration of a specific low abundance biomolecule
02/23/2012US20120045819 Binding molecules for human factor viii and factor viii-like proteins
02/23/2012US20120045816 Novel Glycosylated Polypeptides
02/23/2012US20120045785 Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof
02/23/2012US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
02/23/2012US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
02/23/2012US20120045762 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
02/23/2012US20120045755 Her-2 binding antagonists
02/23/2012US20120045472 Biochemically Stabilized HIV-1 ENV Trimer Vaccine
02/23/2012US20120045471 Recombinant parainfluenza virus vaccine comprising heterologous antigens derived from respiratory syncytial virus
02/23/2012US20120045468 Immunogenic Compositions and Uses Thereof
02/23/2012US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
02/23/2012US20120045463 Methods and compositions comprising supramolecular constructs
02/23/2012US20120045457 Nontypable haemophilus influenzae antigens
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045439 Tumor markers and methods of use thereof
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/23/2012CA2846000A1 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain
02/23/2012CA2808596A1 Modified relaxin polypeptides and their uses
02/23/2012CA2808392A1 Binding proteins for hepcidin
02/23/2012CA2807425A1 Novel bacillus thuringiensis gene with coleopteran activity
02/23/2012CA2807375A1 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012CA2807343A1 Designer osteogenic proteins
02/23/2012CA2807171A1 Novel bacillus thuringiensis gene with lepidopteran activity
02/23/2012CA2806471A1 Novel peptides which have analgesic effects and which inhibit asic channels
02/22/2012EP2420842A1 In vivo imaging of calcified lesions
02/22/2012EP2420830A1 Chloride transporter ClC-7 and cell-based screening method
02/22/2012EP2420563A1 Method for denucleating nucleated erythrocyte, and denucleation inducer
02/22/2012EP2420512A2 Anti-VEGF antibodies
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 2916